CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind ...
MarketWatch (press release)
MENLO PARK, Calif., Jun 07, 2012 (BUSINESS WIRE) -- CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has begun enrollment in PARACHUTE III, a post-market safety surveillance ...
CardioKinetix commences Parachute Ventricular Partitioning Device clinical ...News-Medical.net

all 4 news articles »